the pathophysiology of deep-vein thrombosis ( dvt ) and pulmonary embolism ( pe ) is briefly discussed , and the efficacy , dosage and administration , laboratory monitoring , and adverse effects of thrombolytic agents , heparin , and warfarin are reviewed .
C0034065
pulmonary embolism
C0019134
heparin